Sfoglia per Autore
Use of Enzymatically Activated Carbon Monoxide Donors for Sensitizing Drug-Resistant Tumor Cells
2023-01-01 Sodano, Federica; Rolando, Barbara; Lazzarato, Loretta; Costamagna, Costanzo; Failla, Mariacristina; Riganti, Chiara; Chegaev, Konstantin
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer
2022-01-01 Salaroglio, Iris C; Belisario, Dimas Carolina; Akman, Muhlis; La Vecchia, Sofia; Godel, Martina; Anobile, Dario Pasquale; Ortone, Giacomo; Digiovanni, Sabrina; Fontana, Simona; Costamagna, Costanzo; Rubinstein, Menachem; Kopecka, Joanna; Riganti, Chiara
Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein
2022-01-01 Abd-ellatef G.E.F.; Gazzano E.; El-Desoky A.H.; Hamed A.R.; Kopecka J.; Belisario D.C.; Costamagna C.; S. Marie M.A.; Fahmy S.R.; Abdel-Hamid A.-H.Z.; Riganti C.
Plant-Derived Trans-β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells through Cannabinoid Type 2 Receptor Stimulation
2021-01-01 Geddo, Federica; Antoniotti, Susanna; Querio, Giulia; Salaroglio, Iris Chiara; Costamagna, Costanzo; Riganti, Chiara; Gallo, Maria Pia
Mrp1-collateral sensitizers as a novel therapeutic approach in resistant cancer therapy: An in vitro and in vivo study in lung resistant tumor
2020-01-01 Riganti C.; Giampietro R.; Kopecka J.; Costamagna C.; Abatematteo F.S.; Contino M.; Abate C.
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells
2019-01-01 Salaroglio, Iris Chiara; Abate, Carmen; Rolando, Barbara; Battaglia, Luigi; Gazzano, Elena; Colombino, Elena; Costamagna, Costanzo; Annovazzi, Laura; Mellai, Marta; Berardi, Francesco; Capucchio, Maria Teresa; Schiffer, Davide; Riganti, Chiara
Mitochondrial delivery of phenol substructure triggers mitochondrial depolarization and apoptosis of cancer cells
2018-01-01 Gazzano, Elena; Lazzarato, Loretta; Rolando, Barbara; Kopecka, Joanna; Guglielmo, Stefano; Costamagna, Costanzo; Chegaev, Konstantin*; Riganti, Chiara
New tetrahydroisoquinoline derivatives overcome pgp activity in brain-blood barrier and glioblastoma multiforme in vitro
2018-01-01 Salaroglio, Iris Chiara; Gazzano, Elena; Kopecka, Joanna; Chegaev, Konstantin; Costamagna, Costanzo; Fruttero, Roberta; Guglielmo, Stefano*; Riganti, Chiara
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma
2016-01-01 Buondonno, Ilaria; Gazzano, Elena; Jean, Sae Rin; Audrito, Valentina; Kopecka, Joanna; Fanelli, Marilù; Salaroglio, Iris C; Costamagna, Costanzo; Roato, Ilaria; Mungo, Eleonora; Hattinger, Claudia M; Deaglio, Silvia; Kelley, Shana O; Serra, Massimo; Riganti, Chiara
Gold-containing bioactive glasses: a solid-state synthesis to produce alternative biomaterials for bone implantations
2013-01-01 Valentina Aina; Giuseppina Cerrato; Gianmario Martra; Loredana Bergandi; Costanzo Costamagna; Dario Ghigo; Gianluca Malavasi; Gigliola Lusvardi; Ledi Menabue
Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation
2013-01-01 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardiac glycosides as new modulators of cholesterol metabolism
2012-01-01 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Digoxin and ouabain induce the efflux of cholesterol via LXR signalling and the synthesis of ATP in cardiomyocytes.
2012-01-01 Campia I; Sala V; Kopecka J; Leo C; Mitro N; Costamagna C; Caruso D; Pescarmona G; Crepaldi T; Ghigo D; Bosia A; Riganti C.
Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells.
2011-01-01 Riganti C; Voena C; Kopecka J; Corsetto PA; Montorfano G; Enrico E; Costamagna C; Rizzo AM; Ghigo D; Bosia A
Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells
2010-01-01 I. Campia; C. Riganti; C. Voena; J. Kopecka; E. Enrico; C. Costamagna; D. Ghigo; A. Bosia
Fluoride effects: the two faces of janus
2010-01-01 Gazzano E; Bergandi L; Riganti C; Aldieri E; Doublier S; Costamagna C; Bosia A; Ghigo D
Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells
2008-01-01 Riganti C; Doublier S; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells
2008-01-01 Doublier S; Riganti C; Voena C; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
The NADPH oxidase inhibitor apocynin induces nitric oxide synthesis via oxidative stress
2008-01-01 RIGANTI C; COSTAMAGNA C; DOUBLIER S; MIRAGLIA E; POLIMENI M; BOSIA A; GHIGO D
Studio dei meccanismi di citotossicità e genotossicità di nanoparticelle di silice e silicati fibrosi nanometrici con dimensioni, struttura e composizione strettamente controllate
2007-01-01 Fenoglio I.; Fubini B.; Ghibaudi E.; Ghigo D.; Ghiazza M.; Gazzano E.; Costamagna C.; Colombatto S.; Cravanzola C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Use of Enzymatically Activated Carbon Monoxide Donors for Sensitizing Drug-Resistant Tumor Cells | 2023 | Sodano, Federica; Rolando, Barbara; Lazzarato, Loretta; Costamagna, Costanzo; Failla, Mariacristina; Riganti, Chiara; Chegaev, Konstantin | |
| Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer | 2022 | Salaroglio, Iris C; Belisario, Dimas Carolina; Akman, Muhlis; La Vecchia, Sofia; Godel, Martina; Anobile, Dario Pasquale; Ortone, Giacomo; Digiovanni, Sabrina; Fontana, Simona; Costamagna, Costanzo; Rubinstein, Menachem; Kopecka, Joanna; Riganti, Chiara | |
| Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein | 2022 | Abd-ellatef G.E.F.; Gazzano E.; El-Desoky A.H.; Hamed A.R.; Kopecka J.; Belisario D.C.; Costamagna C.; S. Marie M.A.; Fahmy S.R.; Abdel-Hamid A.-H.Z.; Riganti C. | |
| Plant-Derived Trans-β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells through Cannabinoid Type 2 Receptor Stimulation | 2021 | Geddo, Federica; Antoniotti, Susanna; Querio, Giulia; Salaroglio, Iris Chiara; Costamagna, Costanzo; Riganti, Chiara; Gallo, Maria Pia | |
| Mrp1-collateral sensitizers as a novel therapeutic approach in resistant cancer therapy: An in vitro and in vivo study in lung resistant tumor | 2020 | Riganti C.; Giampietro R.; Kopecka J.; Costamagna C.; Abatematteo F.S.; Contino M.; Abate C. | |
| Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells | 2019 | Salaroglio, Iris Chiara; Abate, Carmen; Rolando, Barbara; Battaglia, Luigi; Gazzano, Elena; Colombino, Elena; Costamagna, Costanzo; Annovazzi, Laura; Mellai, Marta; Berardi, Francesco; Capucchio, Maria Teresa; Schiffer, Davide; Riganti, Chiara | |
| Mitochondrial delivery of phenol substructure triggers mitochondrial depolarization and apoptosis of cancer cells | 2018 | Gazzano, Elena; Lazzarato, Loretta; Rolando, Barbara; Kopecka, Joanna; Guglielmo, Stefano; Costamagna, Costanzo; Chegaev, Konstantin*; Riganti, Chiara | |
| New tetrahydroisoquinoline derivatives overcome pgp activity in brain-blood barrier and glioblastoma multiforme in vitro | 2018 | Salaroglio, Iris Chiara; Gazzano, Elena; Kopecka, Joanna; Chegaev, Konstantin; Costamagna, Costanzo; Fruttero, Roberta; Guglielmo, Stefano*; Riganti, Chiara | |
| Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma | 2016 | Buondonno, Ilaria; Gazzano, Elena; Jean, Sae Rin; Audrito, Valentina; Kopecka, Joanna; Fanelli, Marilù; Salaroglio, Iris C; Costamagna, Costanzo; Roato, Ilaria; Mungo, Eleonora; Hattinger, Claudia M; Deaglio, Silvia; Kelley, Shana O; Serra, Massimo; Riganti, Chiara | |
| Gold-containing bioactive glasses: a solid-state synthesis to produce alternative biomaterials for bone implantations | 2013 | Valentina Aina; Giuseppina Cerrato; Gianmario Martra; Loredana Bergandi; Costanzo Costamagna; Dario Ghigo; Gianluca Malavasi; Gigliola Lusvardi; Ledi Menabue | |
| Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation | 2013 | I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti | |
| Cardiac glycosides as new modulators of cholesterol metabolism | 2012 | I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti | |
| Digoxin and ouabain induce the efflux of cholesterol via LXR signalling and the synthesis of ATP in cardiomyocytes. | 2012 | Campia I; Sala V; Kopecka J; Leo C; Mitro N; Costamagna C; Caruso D; Pescarmona G; Crepaldi T; Ghigo D; Bosia A; Riganti C. | |
| Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells. | 2011 | Riganti C; Voena C; Kopecka J; Corsetto PA; Montorfano G; Enrico E; Costamagna C; Rizzo AM; Ghigo D; Bosia A | |
| Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells | 2010 | I. Campia; C. Riganti; C. Voena; J. Kopecka; E. Enrico; C. Costamagna; D. Ghigo; A. Bosia | |
| Fluoride effects: the two faces of janus | 2010 | Gazzano E; Bergandi L; Riganti C; Aldieri E; Doublier S; Costamagna C; Bosia A; Ghigo D | |
| Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells | 2008 | Riganti C; Doublier S; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A | |
| RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells | 2008 | Doublier S; Riganti C; Voena C; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A | |
| The NADPH oxidase inhibitor apocynin induces nitric oxide synthesis via oxidative stress | 2008 | RIGANTI C; COSTAMAGNA C; DOUBLIER S; MIRAGLIA E; POLIMENI M; BOSIA A; GHIGO D | |
| Studio dei meccanismi di citotossicità e genotossicità di nanoparticelle di silice e silicati fibrosi nanometrici con dimensioni, struttura e composizione strettamente controllate | 2007 | Fenoglio I.; Fubini B.; Ghibaudi E.; Ghigo D.; Ghiazza M.; Gazzano E.; Costamagna C.; Colombatto S.; Cravanzola C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile